Hepatitis E as a trigger for acute-on-chronic liver failure
- PMID: 39523715
- PMCID: PMC11925444
- DOI: 10.3350/cmh.2024.0758
Hepatitis E as a trigger for acute-on-chronic liver failure
Abstract
Acute hepatitis E virus (HEV) infection is typically self-limiting and has a favourable prognosis. However, certain populations such as patients with pre-existing chronic liver disease may experience severe manifestations, including progression to acute-on-chronic liver failure (ACLF). Among viral hepatitis types, hepatitis A, E, and B are major causes of ACLF. Active screening and early diagnosis of HEV infection in patients with cirrhosis, especially those who develop ACLF, can improve management and enable timely antiviral therapy. Preventive measures, including HEV vaccination for high-risk groups, could reduce the morbidity and mortality associated with hepatitis E.
Keywords: Acute on chronic liver failure; Hepatitis E; Liver cirrhosis; Ribavirin; Vaccination.
Conflict of interest statement
Maria Buti advisory board and/or speakers’ bureau fees: AbbVie, Altimmune, Janssen, GlaxoSmithKline, Gilead and Roche; Grants: Gilead. Mar Riveiro-Barciela: advisory board and/or speakers’ bureau fees: Bristol Myers Squibb, Gilead, GlaxoSmithKline; Grants: Gilead.
Figures
References
-
- European Association for the Study of the Liver EASL Clinical Practice Guidelines on hepatitis E virus infection. J Hepatol. 2018;68:1256–1271. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
